R.O. Casasnovas (France) C. Chang (USA) B . Chiu (USA) A . Delmer (France)

1. Comité Scientifique Scientific Committee Access to the Faculty of Medicine 7 boulevard Jeanne d'Arc - Dijon Airport Dijon-Bourgogne Regular flights from Bordeaux, Toulouse, Nantes, Nevers… Train - Tramway From the Railway station Dijon Ville : take Line1 to "Quetigny", stop at "CHU-Hôpitaux". Car When arrivieng in Dijon, follow « DIJON Université ». Taxi Dijon Taxi, call center : 03 80 41 41 12 R.O. Casasnovas(France) C. Chang (USA) B. Chiu (USA) A. Delmer (France) K. EkstromSmedby(Sweden) P. Gaulard(France) T. Lamy de la Chapelle (France) V. Leblond (France) S. Le Gouill(France) M. Maynadié(France) A. Monnereau(France) L. Morton(USA) N. Rothman (USA) G. Salles (France) S. Slager(USA) X. Troussard(France) C. Vajdic (Australia) A. van den Berg (Netherlands) S. Wang (USA) Joint meeting 2013 InterLymph Symposium 2e Journée d’Epidémiologie des Hémopathies Malignes Lymphoma aetiology and prognosis, the role of environment and genetic susceptibility June 24- 26, 2013 Dijon, France Partenaires

2. 2013 InterLymph Symposium2e Journée d’Epidémiologie des Hémopathies MalignesLymphoma aetiology and prognosis, the role of environment and genetic susceptibility June 24, 2013 June 25, 2013 June 26, 2013 8:00-9:40 Hodgkin Lymphoma Working Group 9:40-10:00 Coffee break / Morning tea 10:00-12:00 Hodgkin Lymphoma Working Group 12:00-01:00 Working Lunch INTERLYMPH Business meeting 01:00-02:00 Family studies working group 02:00-03:00 International Multiple Myeloma Consortium 03:00-03:20 Coffee break/Afternoon tea 03:20-06:00 International Multiple Myeloma Consortium 9:00 Registration 9:45 Welcome(M Maynadié) 10:00-11:30Latest findings from the InterLymph Consortium [chairs : S Wang – X Troussard] 10:00-10:20  Comparison of risk factors for all subtypes (L Morton) 10:20-10:40  Key risk factors for rarer B-cell subtypes(A Monnereau/P Bracci) 10:40-11:00  Genome-wide association study (GWAS) of non-Hodgkin lymphoma subtypes : an overview (N Rothman) 11:00-11:20 Interaction between autoimmune disease and immune polymorphisms in risk of non-Hodgkin lymphoma (S Wang) 11:20-11:30  Discussion 11:30-12:00 Coffee break / Morning tea / Poster session 12:00-01:30Lymphoma and Survival[chairs : K Ekstrom-Smedby – T Lamy] 12:00-12:20  Survival of lymphoma in Europe (M Sant) 12:20-12:40  Lifestyle factors and non-Hodgkin lymphoma survival(A Seniori) 12:40-01:00  Prognostic Factors in Lymphoma: Can observational epidemiology studies get the same answers as RCTs? (J Cerhan) 01:00-01:20   Germline genetic variation and lymphoma outcomes(H Ghesquieres) 01:20-01:30  Discussion 01:30-02:20Lunch 02:20-03:00Hodgkin Lymphoma [chairs : S Slager - RO Casasnovas] 02:20-02:40  Risk factors for Classical Hodgkin lymphoma(H Hjalgrim) 02:40-03:00  Meta analysis of the GWAS strategy in Hodgkin lymphoma(W Cozen) 03:00-03:20Defining a Predictive Blood Biomarker for FollicularLymphoma(B Nadel) 03:20-03:30  Discussion 03:30-04:00Coffee break / Afternoon tea / Poster session 04:00-05:30Round table: Second cancer in lymphoid malignancies[chairs : L. Morton – G Salles] 04:00-04:20  K2-France Project (J Jégu) 04:20-04:40  K2-France: second cancer in Follicular Lymphoma and in DLBCL(C Rossi) 04:40-05:00  Second cancer in Follicular Lymphoma included in clinical trials(C Thieblemont) 05:00-05:20  K2-France: second cancer in CLL(X Troussard) 05:20-05:30  Discussion 05:30Wrap-up(M Maynadié) 7:30-8:00  On-site Registration 8:00-10:00  Pathology /Survival working group meeting Subtypes Initiative 10:00-10:30 Coffee break / Morning tea 10:30-012:30Immunology and Infection working group 12:30-02:00Lunch Group photo 02:00-04:00 Lifestyle and Environment working group 04:00-04:30 Coffee break/Afternoon tea 04:30-06:30GWAS Initiative 06:30Dinner